{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,24]],"date-time":"2023-09-24T05:26:21Z","timestamp":1695533181598},"reference-count":9,"publisher":"American Society of Hematology","issue":"14","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2015,10,1]]},"DOI":"10.1182\/blood-2015-08-664060","type":"journal-article","created":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T12:27:26Z","timestamp":1443702446000},"page":"1638-1639","update-policy":"http:\/\/dx.doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":3,"title":["Is the open mouth mightier than the needle?"],"prefix":"10.1182","volume":"126","author":[{"given":"Peter","family":"Martin","sequence":"first","affiliation":[{"name":"WEILL CORNELL MEDICAL COLLEGE"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"234","reference":[{"issue":"14","key":"2019111903025019400_B1","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1182\/blood-2015-05-647834","article-title":"Activity of ibrutinib in mantle cell lymphoma patients with central nervous system relapse.","volume":"126","author":"Bernard","year":"2015","journal-title":"Blood"},{"issue":"1","key":"2019111903025019400_B2","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1093\/annonc\/mdm447","article-title":"Central nervous system involvement in mantle cell lymphoma.","volume":"19","author":"Ferrer","year":"2008","journal-title":"Ann Oncol"},{"issue":"1","key":"2019111903025019400_B3","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1365-2141.2009.07835.x","article-title":"Mantle cell lymphoma with central nervous system involvement: frequency and clinical features.","volume":"147","author":"Gill","year":"2009","journal-title":"Br J Haematol"},{"issue":"8","key":"2019111903025019400_B4","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1093\/annonc\/mdt139","article-title":"Central nervous system involvement in mantle cell lymphoma: clinical features, prognostic factors and outcomes from the European Mantle Cell Lymphoma Network.","volume":"24","author":"Cheah","year":"2013","journal-title":"Ann Oncol"},{"issue":"5","key":"2019111903025019400_B5","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1093\/annonc\/mdv074","article-title":"Ki-67 is a strong predictor of central nervous system relapse in patients with mantle cell lymphoma (MCL).","volume":"26","author":"Chihara","year":"2015","journal-title":"Ann Oncol"},{"issue":"20","key":"2019111903025019400_B6","doi-asserted-by":"crossref","first-page":"e595","DOI":"10.1200\/JCO.2011.34.7252","article-title":"Regression of refractory intraocular large B-cell lymphoma with lenalidomide monotherapy.","volume":"29","author":"Rubenstein","year":"2011","journal-title":"J Clin Oncol"},{"issue":"3","key":"2019111903025019400_B7","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1212\/WNL.0000000000001158","article-title":"Lenalidomide monotherapy as salvage treatment for recurrent primary CNS lymphoma.","volume":"84","author":"Houillier","year":"2015","journal-title":"Neurology"},{"issue":"21","key":"2019111903025019400_B8","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V124.21.627.627","article-title":"Ibrutinib and rituximab are an efficacious and safe combination in relapsed mantle cell lymphoma: preliminary results from a phase II clinical trial [abstract].","volume":"124","author":"Wang","year":"2014","journal-title":"Blood"},{"issue":"suppl 1","key":"2019111903025019400_B9","first-page":"S100","article-title":"Phase I\/II study of TEDDI-R with ibrutinib in untreated and relapsed\/refractory primary CNS lymphoma.","volume":"33","author":"Dunleavy","year":"2015","journal-title":"Hematol Oncol"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/126\/14\/1638\/1388796\/1638.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/126\/14\/1638\/1388796\/1638.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,19]],"date-time":"2019-11-19T03:03:03Z","timestamp":1574132583000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/126\/14\/1638\/34415\/Is-the-open-mouth-mightier-than-the-needle"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,1]]},"references-count":9,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2015,10,1]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2015-08-664060","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,1]]}}}